D. E. Shaw & Co »

Zenas Biopharma shares owned by D. E. Shaw & Co

Quarter-by-quarter ownership of Zenas Biopharma shares owned by D. E. Shaw & Co from 13F filings

Historical chart of D. E. Shaw & Co investment in Zenas Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Zenas Biopharma held by D. E. Shaw & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zenas Biopharma by D. E. Shaw & Co

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.1M 3.0M 1.04

More positions owned by D. E. Shaw & Co

NVIDIA Corporation (NVDA)
Microsoft Corporation Put Option (MSFT)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom Call Option (AVGO)
Apple Put Option (AAPL)
Alphabet Cap Stk Cl C Call Option (GOOG)
Micron Technology Put Option (MU)
Meta Platforms Cl A Call Option (META)
Amazon (AMZN)
Boston Scientific Corporation Call Option (BSX)
Advanced Micro Devices Put Option (AMD)
Taiwan Semiconductor Manufac Sponsored Ads Call Option (TSM)
JPMorgan Chase & Co. Call Option (JPM)
Palantir Technologies Cl A Call Option (PLTR)

View all positions for D. E. Shaw & Co

Top funds holding Zenas Biopharma

Deerfield Management Company
Context Capital Management
Jpmorgan Chase & Co
Braidwell
Jane Street
Citadel Advisors
Leucadia National Corporation
Capstone Investment Advisors
Monashee Investment Management
D. E. Shaw & Co
Calamos Advisors
Graham Capital Management
Woodline Partners
Millennium Management
Aristeia Capital

View all funds holding Zenas Biopharma